Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC32439952;9953;9954 chr2:178764788;178764787;178764786chr2:179629515;179629514;179629513
N2AB32439952;9953;9954 chr2:178764788;178764787;178764786chr2:179629515;179629514;179629513
N2A32439952;9953;9954 chr2:178764788;178764787;178764786chr2:179629515;179629514;179629513
N2B31979814;9815;9816 chr2:178764788;178764787;178764786chr2:179629515;179629514;179629513
Novex-131979814;9815;9816 chr2:178764788;178764787;178764786chr2:179629515;179629514;179629513
Novex-231979814;9815;9816 chr2:178764788;178764787;178764786chr2:179629515;179629514;179629513
Novex-332439952;9953;9954 chr2:178764788;178764787;178764786chr2:179629515;179629514;179629513

Information

  • RefSeq wild type amino acid: Q
  • RefSeq wild type transcript codon: CAG
  • RefSeq wild type template codon: GTC
  • Domain: Ig-23
  • Domain position: 5
  • Structural Position: 5
  • Q(SASA): 0.456
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Q/E None None 0.27 N 0.21 0.264 0.258283824007 gnomAD-4.0.0 6.8438E-07 None None None None N None 0 0 None 0 0 None 0 0 8.99394E-07 0 0
Q/R None None 0.001 N 0.117 0.268 0.183819452728 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Q/A 0.2966 likely_benign 0.4062 ambiguous -0.43 Destabilizing 0.329 N 0.291 neutral None None None None N
Q/C 0.6498 likely_pathogenic 0.8205 pathogenic 0.089 Stabilizing 0.995 D 0.321 neutral None None None None N
Q/D 0.4508 ambiguous 0.6415 pathogenic -0.282 Destabilizing 0.704 D 0.153 neutral None None None None N
Q/E 0.0894 likely_benign 0.1114 benign -0.24 Destabilizing 0.27 N 0.21 neutral N 0.501808834 None None N
Q/F 0.7552 likely_pathogenic 0.8751 pathogenic -0.242 Destabilizing 0.981 D 0.348 neutral None None None None N
Q/G 0.3165 likely_benign 0.4766 ambiguous -0.731 Destabilizing 0.495 N 0.288 neutral None None None None N
Q/H 0.212 likely_benign 0.3307 benign -0.554 Destabilizing 0.927 D 0.294 neutral N 0.516818224 None None N
Q/I 0.515 ambiguous 0.6716 pathogenic 0.307 Stabilizing 0.944 D 0.373 neutral None None None None N
Q/K 0.0851 likely_benign 0.1192 benign -0.32 Destabilizing 0.002 N 0.098 neutral N 0.479294666 None None N
Q/L 0.176 likely_benign 0.2612 benign 0.307 Stabilizing 0.425 N 0.321 neutral N 0.519317297 None None N
Q/M 0.4552 ambiguous 0.5674 pathogenic 0.565 Stabilizing 0.981 D 0.305 neutral None None None None N
Q/N 0.3633 ambiguous 0.512 ambiguous -0.709 Destabilizing 0.704 D 0.153 neutral None None None None N
Q/P 0.5835 likely_pathogenic 0.8411 pathogenic 0.092 Stabilizing 0.784 D 0.351 neutral D 0.60143393 None None N
Q/R 0.0852 likely_benign 0.1203 benign -0.181 Destabilizing 0.001 N 0.117 neutral N 0.457777073 None None N
Q/S 0.3192 likely_benign 0.443 ambiguous -0.733 Destabilizing 0.037 N 0.099 neutral None None None None N
Q/T 0.2461 likely_benign 0.3554 ambiguous -0.516 Destabilizing 0.329 N 0.287 neutral None None None None N
Q/V 0.3512 ambiguous 0.4748 ambiguous 0.092 Stabilizing 0.828 D 0.325 neutral None None None None N
Q/W 0.5271 ambiguous 0.758 pathogenic -0.171 Destabilizing 0.995 D 0.337 neutral None None None None N
Q/Y 0.5098 ambiguous 0.6856 pathogenic 0.033 Stabilizing 0.981 D 0.331 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.